Previous works demonstrated that the endocannabinoid system modulates neuroimmunity and as such neuronal and glial functions. In this study results support the notion that CB2 receptor agonists may be a viable therapeutic candidate for HIV-1-associated neurocognitive disorders.
Link: Immunoregulation Of A CB2 Receptor Agonist In A Murine Model Of NeuroAIDS
Year: 2010
DOI: 10.1007/s11481-010-9225-8
Possible to probable range of efficacy of cannabis for treatment of HIV/AIDS according to the results found in this study.
A highly selective CB2R agonist, Gp1a